|
|||||
TazidimeActive Ingredient(s): CeftazidimeFirst Approved by the FDA: November 20, 1985 Pharmaceutical Company: LILLY Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to TazidimeInjection 10g, 10gm/vial, 1g, 1g/50ml, 1gm/vial, 2g, 2g/50ml, 2gm/vial, 500mg, 500mg/vial, 6g, 6gm/vial Related Drug Page(s): Related Search Results for TazidimeWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Tazidime Text Link HTML Code: Related: Tazidime physician review book, teaching Tazidime, reference pharmacist internal generic Tazidime, Tazidime alert title overdosage pharma label, biotech definition national digest Tazidime, details side effects company substance description Tazidime, interactions document help encyclopedia drug Tazidime, Tazidime info pharma, Tazidime medicine manufacturer control, shape natural associated international Tazidime. Ceftazidime forums pertinent identification guide, Ceftazidime alternative what is company description, Ceftazidime efficacy details, Ceftazidime approval posting remedy, Ceftazidime facts meds definition clinical, Ceftazidime tablet. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Tazidime.asp Last Updated June 27 2005 |
|||||